3,3',4,5'-tetrahydroxystilbene and Elevated Cholesterol

3,3',4,5'-tetrahydroxystilbene has been researched along with Elevated Cholesterol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Choi, HK; Chung, MY; Hong, S; Hwang, JT; Kim, HJ; Lee, J; Lee, SH; Park, JH; Park, SW	1

Other Studies

1 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Elevated Cholesterol

Article	Year
Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition. Pharmacological research, 2020, Volume: 161 Topics: Animals; Cholesterol, LDL; Disease Models, Animal; Down-Regulation; Drug Resistance; Hep G2 Cells; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Mice, Inbred C57BL; p300-CBP Transcription Factors; Proprotein Convertase 9; Protein Stability; Receptors, LDL; Rosuvastatin Calcium; Simvastatin; Stilbenes	2020

Article

Year

Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition.

Pharmacological research, 2020, Volume: 161

Topics: Animals; Cholesterol, LDL; Disease Models, Animal; Down-Regulation; Drug Resistance; Hep G2 Cells; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Mice, Inbred C57BL; p300-CBP Transcription Factors; Proprotein Convertase 9; Protein Stability; Receptors, LDL; Rosuvastatin Calcium; Simvastatin; Stilbenes

2020